TY - JOUR T1 - Tumor-specific Localization of Self-assembled Nanoparticle PET/MR Modalities JF - Anticancer Research JO - Anticancer Res SP - 49 LP - 59 VL - 34 IS - 1 AU - ISTVÁN HAJDU AU - GYÖRGY TRENCSÉNYI AU - MAGDOLNA BODNÁR AU - MIKLÓS EMRI AU - GÁSPÁR BÁNFALVI AU - JUDIT SIKULA AU - TERÉZ MÁRIÁN AU - JÓZSEF KOLLÁR AU - GYÖRGY VÁMOSI AU - JÁNOS BORBÉLY Y1 - 2014/01/01 UR - http://ar.iiarjournals.org/content/34/1/49.abstract N2 - Aim: The aim of this work was to synthesize and study in vitro and in vivo nanocarriers used as magnetic resonance imaging (MRI) contrast agents that accumulate in tumor cells specifically overexpressing folate receptors. Materials and methods: Nanoparticles were prepared by self-assembly of poly-γ-glutamic acid and chitosan biopolymers and were complexed with gadolinium ions. Folic acid served as a targeting molecule. Rat hepatocellular carcinoma (HeDe) cells overexpressing folate receptors were used as a model system. For in vivo experiments, HeDe cells were transplanted under the renal capsule of F344 rats. Results: In vitro results showed the significant internalization of nanoparticles into HeDe cells. MRI measurements revealed that targeting nanocarriers accumulated in tumors. The MRI/PET fusion images resulted in the exact localization of tumors. Conclusion: The nanocarrier provides a suitable means for the early diagnosis of tumors based on their overexpression of folate receptors. ER -